Transgene Market Cap

Transgene has a market cap or net worth of €224.54 million as of March 9, 2026. Its market cap has increased by 142.33% in one year.

Market Cap

224.54M

Enterprise Value

238.83M

Revenue

7.58M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.80

Market Cap Chart

Since March 30, 1998, Transgene's market cap has increased from 151.86M to 224.54M, an increase of 47.86%. That is a compound annual growth rate of 1.41%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	224.54M	-14.58%
Dec 31, 2025	262.87M	192.89%
Dec 31, 2024	89.75M	-34.86%
Dec 29, 2023	137.78M	-16.38%
Dec 30, 2022	164.76M	-33.52%
Dec 31, 2021	247.84M	79.73%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Cellectis	228.55M
Innate Pharma	130.28M
MaaT Pharma	128.33M
Adocia	123.44M
Sensorion	121.04M
Genfit	424.26M
ABIONYX Pharma	116.24M
OSE Immunotherapeutics	90.09M

Market Cap Rankings